General Information
Materials from the Centers for Disease Control and Prevention:
- Basic Information on PrEP
- Take Charge: Talk to Your Doctor About PrEP
- Preexposure Prophylaxis for the Prevention of HIV in the United States: A Clinical Practice Guideline
- Preexposure Prophylaxis for the Prevention of HIV in the United States: Clinical Providers’ Supplement
- Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults
- Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex with Men
- Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users
- CDC’s Clinical Studies of Pre-Exposure Prophylaxis for HIV Prevention
- Pre-Exposure Prophylaxis (PrEP) for HIV Prevention, Planning for Potential Implementation in the U.S.
Materials from the U.S. Food and Drug Administration:
Other Sites Providing PrEP Resources:
- AIDS Action Committee
- AIDSmap
- AVAC
- Avert
- The Fenway Institute
- Massachusetts Department of Public Health
- My PrEP Experience
- PrEP Watch
- Project Inform
- San Francisco AIDS Foundation (PrEPFacts project)
- Test Positive Aware Network
Selected Recent Articles About PrEP
Please Note: Research on PrEP is advancing rapidly, and many articles are being published each year. This section focuses heavily on recent news about PrEP in the past 1 to 2 years. For additional articles, especially older materials, please search the HIVandhepatitis, TheBody, Poz, and Beta Blog sites under the terms “PrEP” or “pre-exposure prophylaxis.”
- PrEP deemed cost-effective in the Netherlands. (October 2016, Healio)
- First Statewide PrEP and PEP Education Bill Signed Into Law. (September 2016, Poz)
- Hey healthcare providers of young gay/queer men: Are you telling them about PrEP? (September 2016, Beta Blog)
- Is Bone Density Loss on PrEP Higher Than Previously Believed? (September 2016, Poz)
- Assessing Benefits of Pre-Exposure Prophylaxis Relative to Risks of Drug Resistance. (September 2016, TheBodyPro)
- Dutch model finds PrEP for high-risk gay men is cost-effective at current prices and cost-saving at generic prices. (September 2016, AIDSmap)
- New York clinic outlines how to improve uptake of PrEP by transgender people. (September 2016, AIDSmap)
- PrEP Use May Stunt Bone Growth in Young Men. (September 2016, Poz)
- PrEP, test-and-treat offer most cost-effective methods for HIV prevention. (September 2016, Healio)
- Racial Disparities Seen in PrEP Use Among Young Gay and Bi Men in California. (September 2016, Poz)
- Evidence that “on-demand” PrEP taken before and after sex can prevent HIV. (September 2016, Beta Blog)
- London gay men anticipate some pros and cons of different PrEP methods – but optimal efficacy is key to acceptability. (September 2016, AIDSmap)
- Two Women, Both with Stories Showing How Hard It Is for Women to Get PrEP. (September 2016, AVAC)
- Does PrEP Use Lead to Higher STI Rates Among Gay and Bi Men? (September 2016, Poz)
- Planned Parenthood in Massachusetts Now Offers Truvada as PrEP. (September 2016, Poz)
- Study looks at use of PrEP during pregnancy and breastfeeding. (September 2016, AIDSmap)
- Can We Finally Say That “On-Demand” PrEP Really Does Work? (August 2016, Poz)
- U.S. PrEP study achieves high levels of engagement and adherence among black men who have sex with men. (August 2016, AIDSmap)
- Increasing adherence, tailoring interventions may reduce disparities in PrEP uptake. (August 2016, Healio)
- Making PrEP More Integrated and Available for Primary Care Providers to Prescribe in the U.S. Southeast. (August 2016, TheBodyPro)
- PrEP and PEP Education Bill Awaits Governor’s Signature. (August 2016, Poz)
- PrEP Gets the Green Light in Europe. (August 2016, Poz)
- Women at Risk for HIV Are Often Willing to Take PrEP for Pregnancy. (August 2016, Poz)
- No new HIV infections seen in San Francisco’s Strut PrEP programme. (August 2016, AIDSmap)
- Oral Maraviroc PrEP Protects U.S. Women From HIV in 48-Week Study. (August 2016, TheBodyPro)
- U.K. Court rules PrEP funding within NHS England’s legal jurisdiction. (August 2016, Healio)
- Vaginal bacteria increase HIV susceptibility and may reduce PrEP effectiveness. (August 2016, AIDSmap)
- Zero HIV Transmissions in Major San Francisco PrEP Program. (August 2016, Poz)
- PrEP rollout recipients in France top 1000: full trial results report 97% effectiveness. (July 2016, AIDSmap)
- What Determines Higher PrEP Adherence Among Black Gay and Bi Men? (July 2016, Poz)
- High Court rules NHS England is responsible for funding PrEP. (August 2016, AIDSmap)
- Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most. (July 2016, AIDSmap)
- Nanoparticles containing dolutegravir demonstrate efficacy for PrEP delivery. (July 2016, Healio)
- Australia adopts ambitious plan to use PrEP to ‘virtually eliminate’ HIV by 2020. (July 2016, AIDSmap)
- What we’re learning about new PrEP drugs and delivery methods at AIDS 2016. (July 2016, Beta Blog)
- No Condoms, No Problems in PrEP Study. (July 2016, Healio)
- No More Lip Service: A Demand for PrEP Access from the Transgender Community. (July 2016, Global Forum on MSM and HIV)
- PrEP can further reduce the risk of HIV infection after a partner starts treatment. (July 2016, AIDSmap)
- Young Gay Teens Do Well On PrEP — But They Need More Support. (July 2016, Beta Blog); related coverage from MedPage Today
- PrEP use exceeds 79,000 in U.S. pharmacy survey, but some groups lagging behind. (July 2016, AIDSmap); related coverage from Beta Blog and Poz
- Gay Men at AIDS 2016 Talk PrEP, Chem Sex and Drug Smuggling. (July 2016, TheBodyPro)
- How do you talk about PrEP to young Black men at risk for HIV? (July 2016, Beta Blog)
- PrEP can cut new HIV infections by one-third in next decade. (July 2016, Healio)
- PrEP researchers now focusing on the best ways to get PrEP to people who need it. (July 2016, AIDSmap)
- With 20 Billion Condoms and 3 Million People on PrEP, Could We Reach the UNAIDS HIV Prevention Goal in 5 Years? (July 2016, Beta Blog)
- Experts call for England’s National Health Service to fund PrEP. (July 2016, Healio)
- HIV seroconversion is rare if Truvada PrEP is used consistently. (July 2016, AIDSmap)
- Keeping Gay Men in Care Is a Major Concern for Long-Term PrEP Use. (July 2016, Poz)
- Two Women, Both with Stories Showing How Hard It Is for Women to Get PrEP. (July 2016, Beta Blog)
- Domestic Violence Is Connected to Lower PrEP Adherence Among Women. (June 2016, Poz)
- Five Exciting HIV Prevention Studies We’re Paying Attention to. (June 2016, Beta Blog)
- Major PrEP Studies Underline Importance of Adherence. (June 2016, Poz)
- PrEP Is Popular in San Francisco, but Largely Among White, Older Gay Men. (June 2016, Poz)
- Sex At Sex Parties, PrEP Takes HIV Disclosure Off the Table. (June 2016, Beta Blog)
- AMA calls for increased HIV prevention, PrEP education. (June 2016, Healio)
- PrEP use is rising fast in US, but large racial disparities remain. (June 2016, AIDSmap); related coverage from Healio and Poz
- Women in HIV serodiscordant relationships less likely to take PrEP consistently if they experience intimate partner violence. (June 2016, AIDSmap)
- Despite low uptake, more than half of MSM willing to take PrEP. (June 2016, Healio)
- Introducing PrEP Facts: Women’s Sexuality and HIV Prevention. (June 2016, AVAC)
- Once Again, England Refuses to Make PrEP Widely Available. (June 2016, Poz)
- People who inject drugs have other priorities ahead of PrEP. (June 2016, AIDSmap); related coverage from Poz
- Physicians Are Increasingly Aware of and Willing to Prescribe PrEP. (June 2016, Poz)
- PrEP not cost-effective for people who inject drugs. (June 2016, Healio)
- PrEP-Linked Symptoms Peak in First Month, With Modest Adherence Impact. (June 2016, TheBodyPro)
- STDs Among Gay Men in a New Era of PrEP. (June 2016, Beta Blog)
- Truvada Whores and HIV Prevention: The Queer Communication of PrEP. (June 2016, Poz)
- Cost is biggest barrier to PrEP in Europe, ECDC declares. (June 2016, AIDSmap)
- San Francisco PrEP Program Serves Over 1,000 Clients. (June 2016, Beta Blog)
- PrEP uptake poised to grow as physicians gain insight, stigmas fade. (May 2016, Infectious Disease News)
- New resource: Paying for PrEP. (May 2016, Beta Blog)
- Not If, But When: Gay men gather in Jo-burg to plot PrEP access. (May 2016, AVAC)
- Project Inform and Outshine NW launch new PrEP awareness videos for transgender community. (May 2016, Project Inform)
- It’s a Bird! It’s a Plane! It’s the PrEP Superheroes! (May 2016, Poz)
- Overview of Major PrEP Research Underlines Truvada’s Power to Prevent HIV. (May 2016, Poz)
- Transmitted drug resistance: The other side to the PrEP failure case we’re not talking about. (May 2016, Beta Blog)
- Which men stand to benefit most from access to PrEP? (May 2016, AIDSmap)
- 3 New Studies to Provide and Evaluate PrEP Among Trans People. (April 2016, Poz)
- Recent meth use may indicate need for PrEP, study finds. (April 2016, Beta Blog)
- How Can We Help Young People Under Age 18 Get PrEP? (April 2016, Beta Blog)
- Legal threat causes NHS England to rethink PrEP access to prevent HIV (April 2016, HIV i-base); related coverage from Poz
- Targeting Injection Drug Users with PrEP Is Not the Best Use of Funds. (April 2016, Poz)
- People who use drugs still adherent to PrEP. (April 2016, Beta Blog)
- Introducing Implementation and Access Resources on PrEP Watch. (April 2016, AVAC)
- Studies Begin to Test Long-Acting Antibody Infusions for HIV Prevention. (April 2016, Poz); related coverage from NIAID
- Advances reported in long-acting PrEP. (April 2016, Project Inform)
- PrEP, delivered to your door. (April 2016, Beta Blog)
- Serious kidney problems are rare with PrEP, but increase with older age and better adherence. (April 2016, Project Inform)
- Men Are Not Macaques and Other Lessons from Long-Acting PrEP Study. (March 2016, TheBodyPro)
- From the Front Lines: Gay Men’s Knowledge of New Prevention Strategies. (Spring 2016, CATIE)
- The Resonance Project: What Service Providers Are Saying About Biomedical Information on HIV Prevention. (Spring 2016, CATIE)
- Women Need to Adhere Better to PrEP Than Men to Be Protected Against HIV. (March 2016, Poz)
- England’s PrEP policy in disarray after NHS U-turn. (March 2016, AIDSmap); related coverage from AVAC and Poz
- Injectable Long-Acting Isentress as PrEP Protects Mice Against Vaginal HIV Exposure. (March 2016, Poz)
- New NRTI MK-8591 (EFdA): weekly oral dosing and once-yearly slow-release dosing has potential for HIV treatment and PrEP. (March 2016, HIV Treatment Bulletin)
- Tailored programmes encourage black gay men to start and stay on PrEP in US study. (March 2016, AIDSmap); related coverage from
Project Inform - PrEP’s Arrival in San Francisco Coincided with Accelerated Increase in Sexual RiskTaking in Gay and Bi Men. (March 2016, Poz)
- High sexually transmitted infection rates among men on PrEP supports more frequent monitoring. (March 2016, AIDSmap)
- Rapid rise in PrEP awareness in US gay men, but only 5% have used PrEP (AIDSmap)
- Meet the Man Who Got HIV While on Daily PrEP. (March 2016, Poz)
- Canada and Israel OK Truvada as PrEP to Prevent HIV. (March 2016, Poz)
- As many as 185,000 new HIV infections in the U.S. could be prevented by expanding testing, treatment, PrEP. (February 2016, CDC); related coverage from AIDSmap, Poz, Healio, and TheBody
- Almost-certain case of PrEP failure due to drug resistance reported at Retrovirus Conference conference. (February 2016, AIDSmap); related coverage from Beta Blog, Poz, Project Inform, and TheBody
- CDC guidelines on STI testing for PrEP patients may miss cases. (February 2016, Healio); related coverage from Poz and 2016 Retrovirus Conference
- Condom use in French PrEP trial: half only used PrEP, a quarter used condoms and PrEP, one in six used neither. (February 2016, AIDSmap)
- Injectable long-acting cabotegravir shows promise as PrEP in early safety trial. (February 2016, Poz); related coverage from AIDSmap and abstract from 2016 Retrovirus Conference
- Maraviroc-containing regimens safe, tolerable when taken for HIV prevention (February 2016, National Institute of Allergy and Infectious Diseases – NIAID); related coverage from Poz
- NIH-funded study finds critical population adheres to PrEP with coordinated care. (February 2016, NIAID)
- NIH-funded study finds effect of PrEP on bone density is reversible. (February 2016, NIAID); related coverage from AIDSmap, Beta Blog, and Healio)
- PrEP uptake and use by Black men who have sex with men in 3 U.S. cities. (February 2016, Retrovirus Conference)
- Tailored counseling approach increases PrEP intake among Black MSM (February 2016, Healio)
- Tenofovir alafenamide PrEP protects monkeys from infection, but rectal and vaginal levels in humans may be too low. (February 2016, AIDSmap)
- Truvada as PrEP against HIV leads to modest decline in kidney function (Poz); related coverage from AIDSmap, Beta Blog, and in CROI abstract 1 and abstract 2
- What is a drug “tail,” and what does it have to do with long-acting PrEP? (February 2016, Beta Blog)
- What’s on the horizon? New PrEP options presented at Retrovirus Conference 2016. (February 2016, Beta Blog)
- PrEP use rising among high-risk gay men in Washington State. (February 2016, AIDSmap)
- Combination nanotherapy drastically reduces the amount of HIV produced by cells in mice. (February 2016, AIDSmap)
- Gilead Seeks Approval of Truvada as PrEP in Europe. (February 2016, Poz)
- London sexual health clinics step up their support for people buying PrEP online. (January 2016, AIDSmap)
- We Aren’t the Sex Police: What PrEP Providers Say About Condoms & STIs. (January 2016, Beta Blog)
- ‘Start-up syndrome’ affects some Truvada users for short period. (January 2016, Healio)
- New PrEP studies will be a challenge, statisticians warn. (January 2016, AIDSmap)
- PrEP Educational Resources for Transgender People Launch January 22. (January 2016, Project Inform)
- Tenofovir Alone as PrEP May Fail. (January 2016, Poz)
- UK strategy could prevent 7,400 MSM HIV infections by 2020. (January 2016, Healio)
- PrEP, plus increased testing and treatment, could prevent nearly half of HIV infections in gay men in the UK by 2020. (January 2016, AIDSmap)
- PrEP Could Halve HIV Rate in British Gay Men. (January 2016, Poz)
- Two cases of PrEP failure on solo tenofovir pose significant research questions. (January 2016, AIDSmap)
- Short- or Medium-Term PrEP Is Safer Than Aspirin. (January 2016, Poz)
- Annual testing and scale-up of PrEP could slow the Dutch gay HIV epidemic. (January 2016, AIDSmap)
- ViiV and Janssen Secure Plans to Develop Long-Acting HIV Treatment. (January 2016, Poz)
- Lessons learnt from the history of contraception are relevant for the implementation of PrEP. (January 2016, AIDSmap)
- Modeling does the math to add up impacts of HIV answers in the works. (January 2016, Science Speaks Blog)
- Sexy PrEP Ads Appeal to Pleasure. (December 2015, Beta Blog)
- Is it important for PrEP programs to talk about sex and pleasure, not just prevention? (December 2015, Beta Blog)
- PrEP Protects Breastfeeding Infants from HIV for Up to a Year. (December 2015, Poz)
- Drug Resistance from Truvada as PrEP Does Not Last. (December 2015, Poz)
- Evidence for PrEP efficacy grows, but implementation presents challenges. (December 2015, AIDSmap)
- No New HIV Infections in San Francisco Community PrEP Clinic. (December 2015, Beta Blog)
- Discussion of HIV prevention strategies generates ‘enthusiasm and excitement.’ Video dated December 2015, Healio)
- Drug resistance acquired during HIV PrEP rapidly disappears after medication is discontinued. (December 2015, AIDSmap)
- Ipergay PrEP study results published. (December 2015, AIDSmap)
- Many more people could benefit from HIV PrEP but not enough doctors are aware, says CDC. (December 2015, AIDSmap)
- Non-Daily PrEP Study Raises Doubts of Its Real-World Applicability. (December 2015, Poz)
- CDC Says 1.2 Million Americans Are Likely Candidates for PrEP. (November 2015, Poz)
- France approves PrEP. (November 2015, AIDSmap)
- Mon Dieu, France Approves PrEP! (November 2015, Poz)
- Barcelona clinic study counts how many gay men might benefit from PrEP. (November 2015, AIDSmap)
- Very Low HIV Rate in Study of High-Risk Gays on PrEP. (November 2015, Poz)
- PrEP Works if You Take It for Trans Women Too. (November 2015, Poz)
- Truvada PrEP appears to work for transgender women, but only if used consistently. (November 2015, AIDSmap)
- First Studies Spur Confidence in New Ways to PrEP. (October 2015, Beta Blog)
- Does Truvada as PrEP Stunt Bone Growth in Young Men? (October 2015, Poz)
- When will Europe get PrEP? (October 2015, AIDSmap)
- New guidelines demonstrate ‘point of clarity’ in managing HIV transmission with PrEP. (October 2015, Healio)
- More Infectious Disease Docs Are Prescribing PrEP. (October 2015, Poz)
- Latinos Deserve Access to PrEP, Too. (October 2015, Beta Blog)
- At least 25,000 people in the US may now be using PrEP. (October 2015, AIDSmap)
- Gay Men’s Sexual Patterns Predict PrEP Dosing Preferences. (October 2015, Poz)
- The Role of PrEP for Transgender Women in Peru. (October 2015, TheBodyPro)
- PrEP preferences in gay men are predicted by the frequency and predictability of the sex they have. (October 2015, AIDSmap)
- WHO guidelines recommend universal antiretroviral treatment, PrEP for those at substantial risk. (September 2015, AIDSmap)
- WHO Calls For HIV Treatment For All, Supports Broader PrEP Use. (September 2015, Poz)
- CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines. (September 2015, CDC)
- Treat All People Living With HIV, Offer Antiretrovirals as PrEP for People at Substantial Risk. (September 2015, WHO)
- WHO ART guideline: Treat all with HIV, offer PrEP to those at “substantial risk.” (September 2015, Science Speaks Blog)
- Rejecting Good Science on PrEP: Why Does it Happen? (September 2015, Beta Blog)
- Bone Density Drops About 1% in HIV-Negative MSM and Transgender Women on PrEP. (September 2015, TheBodyPro)
- Second UK cost-effectiveness study finds that large PrEP programmes may need drug price cut to be affordable. (September 2015, AIDSmap)
- Preventing HIV With Limited Funds? Choose Treatment Over PrEP. (September 2015, Poz)
- Is PrEP 100% Effective or 100% Over-Hyped? (September 2015, TheBodyPro)
- The Overlooked Secondary Benefits of PrEP. (September 2015, TheBodyPro)
- PROUD PrEP study results published. (September 2015, AIDSmap)
- PROUD Study Results Strongly Support UK PrEP Use in New Paper. (September 2015, Poz)
- U.S. PrEP care cascade analysis suggests that major, structural barriers need to be addressed for PrEP to have an impact. (September 2015, AIDSmap)
- Gays Are Talking About PrEP and Viral Load on Social Apps. (September 2015, Poz)
- Half of American gay men using dating apps have interacted with a PrEP user. (September 2015, AIDSmap)
- No HIV infections seen in San Francisco PrEP users referred via primary care. (September 2015, AIDSmap)
- After 2.5 Years, No One in Large SF PrEP Group Contracts HIV. (September 2015, Poz)
- PrEP ‘Care Continuum’ IDs Barriers to Effective HIV Prevention. (September 2015, Poz)
- Highest-Risk Gay and Bi Men Likeliest to Join Brazilian PrEP Study. (August 2015, Poz)
- Where Do I Fit In? PrEP and Transgender Men. (August 2015, Beta Blog)
- AIDS Healthcare Foundation Cedes Ground in Anti-PrEP Fight. (August 2015, Poz)
- PrEP Is Safe for People With Hepatitis B. (August 2015, Poz)
- Daily PrEP lowers hip, spine BMD in HIV-seronegative patients. (August 2015, Healio)
- People with hepatitis B can safely use Truvada PrEP for HIV prevention. (August 2015, AIDSmap)
- Study sheds light on how tenofovir is processed in different body tissues. (August 2015, AIDSmap)
- First Brazilian PrEP data reinforce evidence that PrEP is most used by those at greatest risk. (August 2015, AIDSmap)
- Open-label PrEP in Botswana: very high adherence and no HIV infections seen. (August 2015, AIDSmap)
- Flow Chart for Accessing PrEP for HIV Prevention. (August 2015, Project Inform)
- AIDS Conference Bolsters the Use of HIV Meds as Prevention. (August 2015, Poz)
- PrEP Update: Hopeful Trends but Social Challenges Persist. (July 2015, TheBodyPro)
- Some PrEP Success Among White and Latino Gay Youth. (July 2015, Poz)
- PrEP demo project finds the people at highest HIV risk generally take PrEP most consistently. (July 2015, AIDSmap)
- Daily dosing and text message reminders associated with PrEP adherence in gay men. (July 2015, Project Inform Blog)
- Gay youth PrEP study finds good retention and reasonable adherence. (July 2015, AIDSmap)
- Non-Daily PrEP Likely Works For Anal, Not Necessarily Vaginal, Sex. (July 2015, Poz)
- People with Housing and Higher HIV Risk are More Adherent to PrEP. (July 2015, Beta Blog)
- ATN 110: PrEP Adherence Challenges of Young Black Gay Men. (July 2015, Beta Blog)
- Intermittent PrEP may be a robust strategy for anal sex – vaginal much less certain. (July 2015, AIDSmap)
- The pros and cons of PrEP: trial volunteers recount their experience of the ADAPT study. (July 2015, AIDSmap)
- Adapting PrEP to Match Sex Patterns. (July 2015, Beta Blog)
- New PrEP & women studies: High adherence and effectiveness, but caution for providers. (July 2015, Project Inform Blog)
- Excellent Adherence, No New HIV Cases in Heterosexual PrEP Trial. (July 2015, Poz)
- Gay and Bi Men Adhere Well to PrEP in U.S. Real-World Study. (July 2015, Poz)
- Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing. (July 2015, AIDSmap)
- Study results help guide real-world PrEP implementation. (July 2015, International AIDS Society)
- Vancouver Consensus Statement calls for early access to treatment and PrEP worldwide. (July 2015, AIDSmap)
- Black market for Truvada PrEP may undermine treatment adherence in marginalised people living with HIV. (July 2015, AIDSmap)
- Where next in PrEP and microbicides? Europeans discuss research pipeline. (July 2015, AIDSmap)
- AIDS Healthcare Foundation Issues Latest Anti-PrEP Salvo. (June 2015, Poz)
- Provision of PrEP in the UK will be cost-effective for gay men at high risk of HIV, model finds. (June 2015, AIDSmap)
- PrEP Reaches Top Effectiveness After a Week of Daily Dosing. (May 2015, Poz)
- Prioritisation is crucial for the success of PrEP, model confirms. (May 2015, AIDSmap)
- Truvada PrEP causes only mild loss of bone mineral density. (May 2015, AIDSmap)
- PrEP Prescriptions on Dramatic Upswing in New York State. (May 2015, Poz)
- PrEP-Delivering Subdermal Implant Shows Promise in Animal Study. (May 2015, Poz)
- VIDEO: Expert discusses emerging viruses, hepatitis C treatment, HIV prophylaxis. (May 2015, Healio)
- Injectable PrEP: The Next Order of the Day. (May 2015, Beta Blog)
- Capping Coinsurance Payments for PrEP and HIV Meds. (April 2015, Beta Blog)
- Gay and Bi Men Eager to Enter PrEP Demonstration Project. (April 2015, Poz)
- Truvada as PrEP Leads to Small Initial Decrease in Bone Density. (April 2015, Poz)
- Women in Failed PrEP Trial Lied About Pill Use to Stay In Study. (April 2015, Poz)
- Daily PrEP leads to better adherence and protective drug levels in women. (April 2015, AIDSmap)
- Drug resistance possible risk for PrEP. (April 2015, Healio)
- Poll of HIV Providers Finds Some Reluctance Toward PrEP Prescribing. (April 2015, Poz)
- How Should Providers Incorporate PrEP Into Busy Clinical Practices? (April 2015, TheBodyPro)
- Women in PrEP trial feared they would have to leave study if they reported low adherence. (April 2015, AIDSmap)
- PrEP and Drug Resistance: Cause for Concern? (April 2015, Beta Blog)
- No Matter How You Slice It, PrEP Rollout Should Save Money. (April 2015, Poz)
- How Do We Overcome the Challenges of Accessing PrEP? (March 2015, TheBodyPro)
- PrEP Is Ready for Primetime. (March 2015, Poz)
- Canada: PrEP use now could save considerable sums in the future. (March 2015, AIDSmap)
- Dr. Robert Grant: What Does Ipergay Tell Us About PrEP and ‘Seasons of Risk’? (March 2015, Beta Blog)
- Single Dose of Selzentry Does Not Reach Levels High Enough for PrEP. (March 2015, Poz)
- As PrEP Use in San Francisco Rises, Hope for Cutting HIV Rates. (March 2015, Poz)
- PrEP as bridge to ART highly successful in HIV prevention. (March 2015, Healio)
- Levels of maraviroc in vaginal and rectal tissues may not be high enough for pre-exposure prophylaxis. (March 2015, AIDSmap)
- Prevention, Treatment Combine to Avert HIV Infection. (February 2015, MedPage Today)
- Daily PrEP + ARVs in Mixed-HIV Status Couples = Prevention Success. (February 2015, Poz)
- Combining PrEP and ART could almost eliminate HIV infection, east African study finds. (February 2015, AIDSmap)
- PrEP use high, effective among HIV serodiscordant African couples. (February 2015, Healio)
- Video: PrEP promising, but requires more exploration. (February 2015, Healio)
- Sex-based PrEP cuts infections by 86%. (February 2015, Project Inform)
- Daily PrEP reduces HIV infections by 86% in U.K. PROUD Study. (February 2015, Project Inform)
- Wider PrEP Use in San Francisco Could Cut New HIV Rate by 70%. (February 2015, NATAP)
- PrEP use rising in San Francisco, but scaling up could further cut new infections. (February 2015, AIDSmap)
- Studies Cement Value of HIV Prophylaxis. (February 2015, MedPage Today)
- “On-Demand” PrEP Shows High Efficacy in IPERGAY Trial. (February 2015, Beta Blog)
- Partners PrEP Demo project: Near Elimination of HIV Transmission with ART and PrEP. (February 2015, Beta Blog)
- ‘On-demand’ PrEP regimen successful among MSM. (February 2015, Healio)
- PrEP demonstrates more protection than expected in real-life setting. (February 2015, Healio)
- AVAC calls for rapid response to new ARV-based HIV prevention data presented at CROI, including expedited regulatory review, expanded rollout and updated research plans. (February 2015, AVAC)
- New PrEP Results Exceed HIV Researchers’ High Expectations. (February 2015, TheBodyPro)
- PROUD Study of “Real World” PrEP Reports 86% Efficacy. (February 2015, Beta Blog)
- Study shows “Near elimination of HIV transmission” in a demonstration of PrEP as a bridge to treatment. (February 2015, Science Speaks Blog)
- PrEP, microbicide findings show divergent paths of prevention responses. (February 2015, Science Speaks Blog)
- Intercourse-Based PrEP Dosing Lowers HIV Risk in Gays, But Why? (February 2015, Poz)
- Pre-exposure prophylaxis (PrEP) stops 86% of HIV infections in PROUD study. (February 2015, AIDSmap)
- Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study. (February 2015, AIDSmap)
- PrEP Reduces Group of Gay Men’s Risk of HIV By 86% in UK Study. (February 2015, Poz)
- PrEP-ing for Prevention at CROI 2015. (February 2015, Beta Blog)
- Women and PrEP: The Bridging Role of Local Health Departments. (February 2015, TheBodyPro)
- Clinicians report two acute HCV infections in Kaiser San Francisco PrEP programme. (February 2015, AIDSmap)
- PrEP in the Spotlight: Sound Bites from Creating Change. (February 2015, Beta Blog)
- PrEP Users Sexually Acquired Hep C Suggests Need for Routine Testing. (February 2015, Poz)
- 10 HIV Prevention Developments to Watch in 2015. (February 2015, AVAC and TheBodyPro)
- Failed VOICE PrEP Trial Failed to Preempt Lies About Adherence. (February 2015, Poz)
- How Well Do Condoms and PrEP Prevent HIV Among Gay and Bi Men? (February 2015, Poz)
- Primate Studies Raise Hope of Eventual Quarterly Injected PrEP. (January 2015, Poz)
- While Rare, Drug Resistance After Contracting HIV on PrEP Can Occur. (January 2015, Poz)
- Gay Men’s Ability to Predict Having Sex Has Implications for PrEP Dosing. (January 2015, Poz)
- CDC Vastly Expands ‘Prevention With Positives’ Guidelines. (January 2015, Poz)
- U.S. guidelines on prevention with people living with HIV now emphasise engagement with care, HIV treatment and social factors. (January 2015, Poz)
- No new HIV infections seen among Kaiser PrEP users. (December 2014, AIDSmap)
- Zero HIV Infections Among PrEP Users With 45% Reporting Less Condom Usage. (December 2014, TheBodyPro)
- Pushing PrEP in HIV ‘Hot Zones’ Better Combats the Virus. (December 2014, Poz)
- 45% of PrEP Users at SF Clinic Report Using Condoms Less Often. (December 2014, Poz)
- 6 Lessons for Health Departments Using PrEP as an HIV Prevention Tool. (December 2014, National Alliance of State and Territorial AIDS Directors.
- Conceiving a Child on Truvada as PrEP Appears Safe. (December 2014, Poz)
- IPERGAY PrEP study shows early efficacy in protecting gay men from HIV: all participants to switch to active drug. (November-December 2014, HIV Treatment Bulletin)
- UK PROUD study to provide PrEP to all participants earlier than expected: planned follow-up to continue to two years. (November-December 2014, HIV Treatment Bulletin)
- NHS urgently needs to make PrEP available, say HIV prevention organisations. (November 2014, AIDSmap)
- Uncertainty About PrEP Persists Among Physicians in the United States. (November 2014, TheBodyPro)
- What Does 2015 Hold in Store for HIV Research? (November 2014, TheBodyPro)
- Truvada PrEP use rising in United States, especially among men. (November 2014, AIDSmap)
- Latest Data on PrEP, Though Patchy, Indicates Rising Use Among Men. (November 2014, Poz)
- Why Women May Not Be Protected From HIV by Intermittent PrEP Dosing. (November 2014, TheBodyPro)
- More PrEP Needed To Prevent HIV Via Vaginal Than Anal Sex. (November 2014, Poz)
- Injectable rilpivirine shows promise in phase I trials – but may work better for anal than vaginal sex. (November 2014, AIDSmap)
- Injectable cabotegravir makes progress towards human efficacy studies: doubts about injectable rilpivirine. (October 2014, AIDSmap)
- Why the IPERGAY (Yes, That’s Its Name) Study Could Substantially Increase Use of PrEP. (October 2014, Journal Watch on TheBodyPro)
- “On Demand” PrEP May Significantly Reduce HIV Risk; IPERGAY Study Halted. (October 2014, TheBodyPro)
- From Routine to Sexy, More PrEP Options Are a Plus for HIV Prevention. (October 2014, TheBody)
- High Efficacy Halts Placebo Phase of Intermittent PrEP Study. (October 2014, Poz)
- Second European PrEP study is closed early due to high effectiveness. (October 2014, AIDSmap)
- Calculating PrEP’s Capacity to Prevent HIV in the Real World. (October 2014, Poz)
- High Efficacy for PrEP Among Gay Men in English Study. (October 2014, Poz)
- Long-Acting, Investigational Integrase Inhibitor Cabotegravir Shows Promise. (October 2014, TheBody)
- High effectiveness seen in English PrEP trial. (October 2014, AIDSmap)
- Analysis of PrEP Data Shows High Adherence in U.S., and Among Most at Risk of HIV. (October 2014, TheBody)
- Washington State First to Assist Those Seeking HIV Prevention Pill. (October 2014, TheBody)
- PrEP will need high adherence, high effectiveness and high coverage in specific populations to be affordable in the US, New York study finds. (October 2014, AIDSmap)
- Antiretroviral studies at ICAAC 2014: darunavir-based FDC with TAF, cobicistat, doravirine, Stribild and gel formulation PrEP. (September/October 2014, HIV Treatment Bulletin)